Literature DB >> 24030508

Question 2: Would systemic steroids be useful in the management of Stevens-Johnson syndrome?

Fenella Corrick1, Geetha Anand.   

Abstract

Entities:  

Keywords:  Dermatology; Evidence Based Medicine; Immunology; Paediatric Practice; Syndrome

Mesh：

Substances：

Year:  2013        PMID： 24030508     DOI： 10.1136/archdischild-2013-304909

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  3 in total

1.  Case of Steven-Johnson Syndrome in a male with breast cancer secondary to docetaxel/cyclophosphamide therapy.

Authors:  Benjamin Jarrett; Sehem Ghazala; Joseph Chao; Sachin Chaudhary
Journal:  BMJ Case Rep       Date:  2016-11-15

2.  Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial.

Authors:  Reason Wilken; Chin Shang Li; Victoria R Sharon; Kyoungmi Kim; Falin B Patel; Forum Patel; Emanual Maverakis
Journal:  Trials       Date:  2015-08-22       Impact factor: 2.279

3.  Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Lucia Liotti; Silvia Caimmi; Paolo Bottau; Roberto Bernardini; Fabio Cardinale; Francesca Saretta; Francesca Mori; Giuseppe Crisafulli; Fabrizio Franceschini; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.